2019
DOI: 10.1155/2019/9687823
|View full text |Cite
|
Sign up to set email alerts
|

Multiple Gene Polymorphisms Associated with Exfoliation Syndrome in the Uygur Population

Abstract: Background. Our previous data suggested that three single-nucleotide polymorphisms (SNPs), rs1048661, rs3825942, and rs2165241, of the lysyl oxidase-like 1 gene (LOXL1) are significantly associated with exfoliation syndrome (XFS) and exfoliation glaucoma (XFG). The following study investigated other SNPs that potentially effect XFS/XFG. Methods. A total of 216 Uygur patients diagnosed with XFS/XFG, and 297 Uygur volunteers were admitted to the First Affiliated Hospital at Xinjiang Medical University between Ja… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
11
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 8 publications
0
11
0
Order By: Relevance
“…Interestingly, though, Uygur populations in China have higher rates of XFS/XFG—with rates as ranging between 2.2% to 9.5% depending on age [ 214 ]. In these populations, LOXL1 SNPs have similarly been identified as risk alleles for XFS/XFG [ 180 , 215 ]. Uygur populations have also shown association with SNPs of TBC1D21 and ATXN2 [ 216 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Interestingly, though, Uygur populations in China have higher rates of XFS/XFG—with rates as ranging between 2.2% to 9.5% depending on age [ 214 ]. In these populations, LOXL1 SNPs have similarly been identified as risk alleles for XFS/XFG [ 180 , 215 ]. Uygur populations have also shown association with SNPs of TBC1D21 and ATXN2 [ 216 ].…”
Section: Discussionmentioning
confidence: 99%
“…In these populations, LOXL1 SNPs have similarly been identified as risk alleles for XFS/XFG [ 180 , 215 ]. Uygur populations have also shown association with SNPs of TBC1D21 and ATXN2 [ 216 ]. Meanwhile, in North Indian populations, rs3925942 has shown a significant association with XFS/XFG [ 217 ], but other SNPs of LOXL1 have shown no association [ 182 ].…”
Section: Discussionmentioning
confidence: 99%
“…; Ma et al. ). Genome‐wide association study (GWASs) and next‐generation sequencing technologies have been used to elucidate potential genetic causal variants underlying XFS, which could help better understanding the disease mechanism and provide specific treatment approaches (Schlötzer‐Schrehardt ).…”
Section: Genetic Factors: Clumentioning
confidence: 98%
“…Research on the genetic risk factors for XFS is an area of intense research, and other susceptibility loci and SNPs have been identified in association with this syndrome in certain populations (Krumbiegel et al 2011;Wiggs et al 2012;Nakano et al 2014;Zagajewska et al 2018;Ma et al 2019). Genomewide association study (GWASs) and next-generation sequencing technologies have been used to elucidate potential genetic causal variants underlying XFS, which could help better understanding the disease mechanism and provide specific treatment approaches (Schl€ otzer-Schrehardt 2018).…”
Section: Genetic Factors: Clumentioning
confidence: 99%
“…SCA2 patients may present with visual phenotypes such as retinal nerve fiber layer thinning, night blindness, ophthalmoparesis, ERG abnormalities, retinal dystrophy, and retinitis pigmentosa (Kurashige et al, 2020;Paciorkowski et al, 2011;Pula et al, 2011;Rufa et al, 2002;Volpe et al, 2015), whereas a recent GWAS study associated ATXN2 SNPs with primary open angle glaucoma (POAG), a leading worldwide cause of irreversible blindness (Bailey et al, 2016;Jonas et al, 2017). Additional ATXN2 polymorphisms have been linked to exfoliation glaucoma (Ma et al, 2019). Taking into account ocular phenotypes and pro-apoptotic impairment of autophagosome formation and stress granule clearance in glaucoma and ALS (Becker et al, 2017;Deluca et al, 2017;de Majo et al, 2018;Fingert et al, 2017;Hirt & Liton, 2017;Kurashige et al, 2020;Paciorkowski et al, 2011;Paul et al, 2018;Porter et al, 2013;Pula et al, 2011;Rufa et al, 2002;Scoles et al, 2017;Volpe et al, 2015), it is conceivable that abnormal intracellular transport, translation, stability, and distribution of mRNAs in chronic ocular neuropathologies might involve ATXN2; yet, there is virtually no information about its ocular localization and expression.…”
mentioning
confidence: 99%